Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the "Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte ...

Colorado regulators have issued the first licenses to individuals looking to enter the state’s emerging psilocybin industry.

Four young children have gained life-changing improvements in sight following treatment with a pioneering new genetic ...

A groundbreaking gene therapy has restored sight in four young children born with severe blindness due to a rare genetic ...

Telix is in a strong financial position with net cash of AUD 140 million as of December 2024. We forecast free cash flow averaging 87% of net income over the next 10 years, and in the absence of major ...

While recruitment and regulation are improving, they remain pain points, say speakers at Arena International’s OCT West Coast ...

Talkspace, Inc. shows promise with AI integration and payor focus, achieving profitability and targeting revenue growth. Click for more on TALK stock prospects.

Evolving regulations link workplace conditions to mental health, driving corporate compliance and increasing investment.

X4 has entered an exclusive agreement with taiba rare for distributing and commercialising Xolremdi in select Middle Eastern ...

The evolution of cell and gene therapy is reshaping drug discovery, providing new hope for rare diseases and cancer through innovative gene editing approaches.

Researchers have suggested that uniform evidence standards and reporting requirements could help speed patient access to cell ...

Trump’s new executive order brings independent agencies under White House review, but now needs congressional backing to ...